Carol Greve-Philips
Corporate Officer/Principal chez Licensing Executives Society
Profil
Carol Greve-Philips is a professional with experience in various firms.
She is currently a member of the Licensing Executives Society.
Her former jobs include Vice President-Corporate Development at Genzyme Corp.
from 2009 to 2011, Principal at Watson Laboratories, Inc., Chief Business Officer at MyCartis NV from 2012 to 2014, Principal at Toxikon Corp., Head-Sales at Chemsyn Science Laboratories, and Head-Business Development & Strategy at Spark Therapeutics, Inc. She completed her undergraduate degree at the University of Massachusetts.
Postes actifs de Carol Greve-Philips
| Sociétés | Poste | Début |
|---|---|---|
| Licensing Executives Society | Corporate Officer/Principal | - |
Anciens postes connus de Carol Greve-Philips
| Sociétés | Poste | Fin |
|---|---|---|
MyCartis NV
 MyCartis NV BiotechnologyHealth Technology MyCartis NV develops technologies for healthcare personalization needs. It offers Evalution, a multiplex analysis platform to develop protein and nucleic-acid based clinical biomarkers. The company provides disruptive solutions in the fields of clinical and translational research for various applications in the detection of proteins and nucleic acids, such as sandwich immunoassays, antibody assays, genotyping assays, and mutation analysis assays to customers and partners. It offers products for various disease areas, including cell signalling, cardiovascular, oncology, and preeclampsia. The company was founded by Koen Kas in August 2004 and is headquartered in Ghent, Belgium. | Corporate Officer/Principal | - |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
| SPARK THERAPEUTICS, INC. | Corporate Officer/Principal | - |
| Chemsyn Science Laboratories | Sales & Marketing | - |
Toxikon Corp.
 Toxikon Corp. Miscellaneous Commercial ServicesCommercial Services Toxikon Corp. provides life science and laboratory services. The firm's services include toxicology, chronic, reproductive and chronic toxicity, genetic toxicology, carcinogenicity, pharmacokinetics, toxicokinetics, and microbiology. It offers services to the pharmaceutical, medical devices, and drug companies. The company was founded in 1977 and is located in Bedford, MA. | Corporate Officer/Principal | - |
Formation de Carol Greve-Philips
| University of Massachusetts | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Watson Laboratories, Inc.
 Watson Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Watson Laboratories, Inc. develops and markets off-patient and proprietary pharmaceutical products. The company is headquartered in Corona, CA. | Health Technology |
MyCartis NV
MyCartis NV BiotechnologyHealth Technology MyCartis NV develops technologies for healthcare personalization needs. It offers Evalution, a multiplex analysis platform to develop protein and nucleic-acid based clinical biomarkers. The company provides disruptive solutions in the fields of clinical and translational research for various applications in the detection of proteins and nucleic acids, such as sandwich immunoassays, antibody assays, genotyping assays, and mutation analysis assays to customers and partners. It offers products for various disease areas, including cell signalling, cardiovascular, oncology, and preeclampsia. The company was founded by Koen Kas in August 2004 and is headquartered in Ghent, Belgium. | Health Technology |
| Licensing Executives Society | |
Toxikon Corp.
Toxikon Corp. Miscellaneous Commercial ServicesCommercial Services Toxikon Corp. provides life science and laboratory services. The firm's services include toxicology, chronic, reproductive and chronic toxicity, genetic toxicology, carcinogenicity, pharmacokinetics, toxicokinetics, and microbiology. It offers services to the pharmaceutical, medical devices, and drug companies. The company was founded in 1977 and is located in Bedford, MA. | Commercial Services |
| Chemsyn Science Laboratories | |
Spark Therapeutics, Inc.
 Spark Therapeutics, Inc. BiotechnologyHealth Technology Spark Therapeutics, Inc. engages in the research, development, and commercialization of gene therapies. Its product portfolio intends to treat inherited retinal sickness, liver-mediated, and neurodegenerative diseases. The company was founded by Jean Bennett, Beverly Davidson, Katherine A. High, Jeffrey D. Marrazzo, J. Fraser Wright, and Jennifer Wellman on March 13, 2013 and is headquartered in Philadelphia, PA. | Health Technology |